Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 10/20 | 1.00 |
| ▸ | FTH1 | P02794 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (-)-Caryophyllene Oxide SCHEMBL16489852 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL18788522 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL1532444 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL127077 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL24110118 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL17857878 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL676309 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL16769854 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL21349931 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL26189380 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025231514-A1 | ANTIVIRAL FORMULATIONS | Vapour Science (AU) | 2025-11-13 | — | — | WO | claimed |
| US-20240238177-A1 | USE OF VOLATILE COMPOUNDS TO MODULATE THE PERCEPTION OF FLORAL MUGUET | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | claimed |
| US-20230380428-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEV LLC (US) | 2023-11-30 | — | — | US | claimed |
| US-20220323371-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-10-13 | — | — | US | claimed |
| EP-3993780-A1 | HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS | Ellevet Sciences (US) | 2022-05-11 | — | — | EP | claimed |
| WO-2022081174-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEVELOPMENT, LLC (US) | 2022-04-21 | — | — | WO | claimed |
| WO-2025231514-A1 | ANTIVIRAL FORMULATIONS | Vapour Science (AU) | 2025-11-13 | — | — | WO | disclosed |
| US-12435053-B2 | Process for preparing caryophyllene oxide | SYMRISE AG (DE) | 2025-10-07 | — | — | US | disclosed |
| EP-4552652-A2 | TERPENE-ENRICHED CANNABINOID COMPOSITION | Buzzelet Development And Technologies Ltd (IL) | 2025-05-14 | — | — | EP | disclosed |
| US-20240316136-A1 | ANESTHETIC METHOD OF SPOTTED SEABASS WITH PLANT ESSENTIAL OILS | SHANGHAI OCEAN UNIVERSITY (CN) | 2024-09-26 | — | — | US | disclosed |
| EP-4426119-A1 | COMPOSITION FOR USE IN PLANTS AND USES THEREOF | Biotech Tricopharming Research S.L. (ES) | 2024-09-11 | — | — | EP | disclosed |
| US-20240238177-A1 | USE OF VOLATILE COMPOUNDS TO MODULATE THE PERCEPTION OF FLORAL MUGUET | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | disclosed |
| US-11985973-B2 | Insect repelling composition | GLOBAL BIOLIFE INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-11618869-B2 | Aromatized effervescent wine and method of making same | Rozoy, Clément (FR) | 2023-04-04 | — | — | US | disclosed |
| US-20220323371-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-10-13 | — | — | US | disclosed |
| US-20220159950-A1 | INSECT REPELLING COMPOSITION | GLOBAL BIOLIFE INC. | 2022-05-26 | — | — | US | disclosed |
| EP-3993780-A1 | HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS | Ellevet Sciences (US) | 2022-05-11 | — | — | EP | disclosed |
| WO-2022081174-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEVELOPMENT, LLC (US) | 2022-04-21 | — | — | WO | disclosed |
| US-11246310-B2 | Insect repelling composition | GLOBAL BIOLIFE INC. (US) | 2022-02-15 | — | — | US | disclosed |
| US-20210387959-A1 | PROCESS FOR PREPARING CARYOPHYLLENE OXIDE | SYMRISE AG (DE) | 2021-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435053-B2 | Process for preparing caryophyllene oxide | POR, SQLE, CBR3 | CYP3A4 99/4885FTH1 845/4885CYP2C9 132/4885 |
| US-20210387959-A1 | PROCESS FOR PREPARING CARYOPHYLLENE OXIDE | POR, SQLE, CBR3 | CYP3A4 99/4885FTH1 845/4885CYP2C9 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.